# Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial

> **NCT03340727** · PHASE3 · TERMINATED · sponsor: **NICHD Neonatal Research Network** · enrollment: 827 (actual)

## Conditions studied

- Apnea of Prematurity

## Interventions

- **DRUG:** Caffeine Citrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03340727
- **Lead sponsor:** NICHD Neonatal Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-27
- **Primary completion:** 2023-01-23
- **Final completion:** 2023-03-20
- **Target enrollment:** 827 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2024-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03340727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03340727, "Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03340727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
